Advertisement
Advertisement
U.S. markets closed
Advertisement
Advertisement
Advertisement
Advertisement

Acutus Medical, Inc. (AFIB)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
8.16-0.51 (-5.88%)
At close: 4:00PM EDT
8.16 0.00 (0.00%)
After hours: 04:00PM EDT
Advertisement
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bearishpattern detected
Momentum

Momentum

Previous Close8.67
Open8.63
Bid8.00 x 1000
Ask8.19 x 1000
Day's Range8.13 - 8.63
52 Week Range7.55 - 34.35
Volume129,354
Avg. Volume375,181
Market Cap228.005M
Beta (5Y Monthly)N/A
PE Ratio (TTM)N/A
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Overvalued

Subscribe to Yahoo Finance Plus to view Fair Value for AFIB

Learn more
View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • Acutus Medical, Inc.
    Daily – Vickers Top Buyers & Sellers for 08/13/2021The Vickers Top Buyers & Sellers is a daily report that identifies the five companies the largest insider purchase transactions based on the dollar value of the transactions as well as the five companies the largest insider sales transactions based on the dollar value of the transactions.
    Rating
    Fair Value
    Economic Moat
    2 months agoArgus Research
View more
  • GlobeNewswire

    Acutus Medical Appoints Niamh Pellegrini to Board of Directors

    CARLSBAD, Calif., Aug. 12, 2021 (GLOBE NEWSWIRE) -- Acutus Medical (“Acutus”) (Nasdaq: AFIB), an arrhythmia management company focused on improving the way cardiac arrhythmias are diagnosed and treated, today announced the appointment of Niamh Pellegrini to the Company's Board of Directors, effective August 10, 2021. Ms. Pellegrini has over 20 years of experience in the healthcare industry and, since July 2019, has served as the Chief Commercial Officer of Nevro, Inc., a medical device company d

  • GlobeNewswire

    Acutus Medical Reports Second Quarter 2021 Financial Results

    CARLSBAD, Calif., Aug. 12, 2021 (GLOBE NEWSWIRE) -- Acutus Medical, Inc. (“Acutus” or the “Company”) (Nasdaq: AFIB), an arrhythmia management company focused on improving the way cardiac arrhythmias are diagnosed and treated, today reported results for the second quarter of 2021. Recent Highlights: Reported revenue of $4.7 million in the second quarter of 2021, compared to $1.1 million in the same quarter last year and $3.6 million in the first quarter of 2021.Increased worldwide installed base

  • GlobeNewswire

    AcQMap 8, Acutus Medical’s Innovative Suite of Software Upgrades, Receives FDA Clearance and CE Mark

    Enhanced Software Automatically Identifies Regions of Interest During the Treatment of Complex Atrial Arrhythmias AcQMap 8 Software with AcQTrack™ and SlowZone™ Locator Case Example: Patient with Atrial Fibrillation Left to right, AcQMap (with input from a clinical specialist), AcQTrack, and SlowZone Locator all independently identify conduction abnormalities in the same anatomical location, providing confidence that the overlapping areas may be contributing to the complex arrhythmia. Physicians

Advertisement
Advertisement